BioSpace News Archive

Protection From Tariffs as an An umbrella that shields against import and export tariff taxes as a trade war storm increasing prices and straining supply chains as a business metaphor and a symbol for resilience in times of crisis and economic downturn.

Policy

NHS Mulls Greater Pharma Spending to Head Off Trump’s Tariffs: Report

The British proposal to increase support for pharma is “clearly positive,” according to analysts at Leerink, who noted that the NHS’ move will improve patient access to treatments.

October 10, 2025

·

2 min read

·

Tristan Manalac

President Donald Trump signs S.1852, The GENIUS Act, Friday, July 18, 2025, in the East Room of the White House. (Official White House Photo by Daniel Torok)

Drug pricing

GoodRx Wants In on Direct-to-Consumer TrumpRx Platform

GoodRx, an online platform that offers drug discount coupons to patients, is in talks with the government to participate in the forthcoming TrumpRx program.

October 10, 2025

·

2 min read

·

Tristan Manalac

Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.

Gene therapy

AviadoBio Looks to China for Eye-Based Gene Therapy in $413M UgeneX Pact

AviadoBio will have the option to exclusively license UGX-202, a vision-restoring gene therapy for the rare eye condition retinitis pigmentosa.

October 10, 2025

·

2 min read

·

Tristan Manalac

External view of Bristol Myers Squibb's office California

Mergers & acquisitions

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover

Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they “continue to look for more” from Bristol Myers Squibb before they can “get excited about the near term turnaround story.”

October 10, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Ferring To Cut 500 Employees as Part of Business Model Shift

Follow along as BioSpace tracks job cuts and restructuring initiatives.

October 10, 2025

·

70 min read

·

BioSpace Editorial Staff

South side and Dome of the US Capitol in Washington DC, United States

BIOSECURE Act

The BIOSECURE Act Is Back, as Congress Tacks New Version On to Broader Defense Bill

A new version of the controversial bill removes the specific company names that were included in a previous iteration but still requires the industry to ditch Chinese biotech contractors in order to receive federal dollars.

October 10, 2025

·

1 min read

·

Annalee Armstrong

Facade of AstraZeneca's office in Shanghai, China

Drug pricing

AstraZeneca Becomes Second Pharma to Strike DTC Deal With Trump Administration

The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in response to the president’s calls to lower U.S. drug prices.

October 10, 2025

·

1 min read

·

Dan Samorodnitsky

Press Releases

Genethon Confirms 2-Year Efficacy in Duchenne Muscular Dystrophy Patients Treated With Its Low Dose Micro-Dystrophin Gene Therapy (GNT0004) at the ESGCT 32nd Annual Congress

October 10, 2025

·

4 min read

Press Releases

Eikonizo Therapeutics Announces Publication in Brain Demonstrating Disease-Modifying Potential of Selective HDAC6 Inhibitors in Preclinical Models of ALS and FTD